Trends in assisted peritoneal dialysis over the last decade: a cohort study from the French Peritoneal Dialysis Registry. by Boyer, A et al.
O R I G I N A L A R T I C L E
Trends in assisted peritoneal dialysis over the last
decade: a cohort study from the French Peritoneal
Dialysis Registry
Annabel Boyer 1,2, Antoine Lanot 1,2,3, Mark Lambie 4,5,
Sonia Guillouet 1,2,3, Thierry Lobbedez1,2,3 and Clémence Béchade1,2,3
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ABSTRACT
Background. There is limited information available on the use of assisted peritoneal dialysis (PD) over time and the impact of
economic incentives on its utilization. The aim of this study was to describe the trends in assisted PD utilization and the
type of assistance provided. We wanted to estimate if an economic incentive implemented in 2011 in France was associated
with an increase in the utilization of nurse-assisted PD.
Methods. This retrospective, multicentre study, based on data from the French Language Peritoneal Dialysis Registry,
analysed 11 987 patients who initiated PD in France between 1 January 2006 and 31 December 2015. Adjusted Cox regression
with robust variance was used to examine the initiation of assisted PD, both nurse-assisted and family-assisted, accounting
for the nonlinear impact of the PD starting time.
Results. There were 6149 (51%) incident patients on assisted PD, 5052 (82%) on nurse-assisted PD and 1097 (18%) on
family-assisted PD over the study period. In the adjusted analysis, calendar time was associated with the assisted PD rate: it
declined from 2008 until 2013 before flattening out and then it increased after 2014. Nurse-assisted PD utilization increased
significantly after 2012, whereas family-assisted PD utilization decreased linearly over time (prevalence ratio ¼ 0.94, 95%
confidence interval 0.92–0.97).
Conclusions. The assisted PD rate decreased until 2013, mainly because of a decline in family-assisted PD. The uptake in
nurse-assisted PD observed from 2013 reflects the effect of an economic incentive adopted in late 2011 to increase PD
utilization.
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INTRODUCTION
The initiation of dialysis can be emotionally challenging for
patients and families; presenting patients with choices of dialy-
sis modality may ease the burden of stress and anxiety. Older
age, comorbidities, physical disabilities and psychosocial prob-
lems act as barriers to home dialysis [1–5].
Compared with in-centre haemodialysis (HD), peritoneal di-
alysis (PD) offers several advantages, such as the avoidance of
transport to and from the dialysis unit, avoidance of difficulties
in creating vascular access and haemodynamic instability dur-
ing the HD session [3, 6–8]. By overcoming some of the condi-
tions that act as a barrier to self-care PD [4, 9], assistance can
improve the accessibility of home dialysis and thus favour qual-
ity of life in elderly patients [3, 9–11].
Home assistance programmes have been implemented in
several countries in recent decades. Depending on the country,
the assistance can be provided by a healthcare technician, a
community nurse, and a trained family member or partner [12].
With the first programmes being implemented in the 1980s,
France has one of the longest experiences of assisted PD [13, 14].
Nurse-assisted PD is fully covered by the French healthcare in-
surance. Notably, assisted PD remains cheaper than in-centre
HD, even after the additional costs for nurse assistance [15].
Assisted PD allows patients to choose their PD modality [e.g. au-
tomatic peritoneal dialysis (APD) or continuous ambulatory PD
(CAPD)] and the type of assistance (nurse or a family-assisted
PD). According to the French Language Peritoneal Dialysis
Registry (RDPLF), >50% of incident patients treated by PD from
1995 to 2006 were considered unable to perform self-care PD
and needed assistance. The assistance was mainly provided by
a private nurse (45%) and to a lesser extent by a family member
(7%). In the elderly population, >80% needed assistance [16].
Strategic economic incentives to increase home dialysis by
altering remuneration for these therapies are being introduced
[17]. Despite these incentives and the many advantages home
dialysis can offer, PD use has been declining in recent decades
[18], while the total number of dialysis patients has increased
[19, 20]. It is unclear whether this decline is linked to an ageing
population, which may be associated with limited use of home
therapy unless assistance is provided. With the population in
CKD growing older and frailer, we could anticipate an increase
in assisted PD use. One may also argue that the possibility of re-
lying on family members for the assistance of PD patients could
have decreased over time. To encourage PD in older patients in
France, nurse-assisted PD in nursing homes became covered by
healthcare insurance in 2011 [21]. To our knowledge, there are
no data in the literature describing the longitudinal trends in
the use of assisted PD.
The aim of this study was to describe the trends in assisted
PD utilization, the trends in the type of assistance provided to PD
patients and the PD modalities used for the assisted PD patients
over the past decade in France. The secondary objective was to
estimate whether the coverage of nurse-assisted PD in nursing
home implemented at the national level in 2011 was associated
with an increase in the utilization of nurse-assisted PD.
MATERIALS AND METHODS
Study population
This was a retrospective study using data from the RDPLF. All
adults >18 years starting PD in France between 1 January 2006
and 31 December 2015 were included. No patient was lost to
follow-up. The RDPLF database has been shown to be reliable,
with coverage of 99% in France in 2016 [22, 23].
Age at PD start, gender, underlying nephropathy, diabetes
mellitus, previous therapy before PD initiation (HD or renal
transplantation), suboptimal starters (defined as a period of
<30 days on HD before PD initiation) and centre category (aca-
demic, community, non-profit and private) were obtained from
the registry [24]. To evaluate patient comorbidities, the
Charlson comorbidity index (CCI) was extracted from the data-
base, and the modified CCI was calculated by subtracting the
age subscore. For centre size estimation, we calculated the
number of incident PD patients per centre per year of participa-
tion during the study period [25].
Events of interest
In the complete cohort, the events of interest were assisted PD,
nurse-assisted PD and family-assisted PD at dialysis initiation.
Assisted PD was defined as PD performed at the patient’s home
with the help of a community nurse (nurse-assisted PD) or a
family member or a partner (family-assisted PD).
We also wanted to evaluate the use of CAPD over time and
the association between type of assistance and PD modality
(CAPD/APD). A second cohort included nurse- and family-
assisted patients. In that part of the analysis, the event of inter-
est was the use of CAPD at dialysis initiation.
To provide additional information, we have also estimated
the occurrence of PD failure, caused by death or transfer to HD,
and renal transplantation during the study period. The time
from PD start to the first episode of peritonitis was also calcu-
lated. Both technique survival and peritonitis rates were evalu-
ated in the complete cohort and in the nurse- and family-
assisted cohort.
Explanatory variable
The main explanatory variable was the time, or PD start year,
between 1 January 2006 and 31 December 2015. For the second-
ary objective, the explanatory variable was the time period fol-
lowing the implementation of the coverage of nurse-assisted PD
in nursing home (the number of years between 2011 and the
year of PD start).
Statistical analysis
Continuous variables were described by the median (first
and third quartile), and categorical variables were described by
frequencies and percentages. Regression splines were used to
explore the functional form of the length of time from the inclu-
sion date until the end of the inclusion period. Transformation
of the continuous time variable to a categorical variable was
performed based on the aspect of the graph of the functional
form of the predictor.
When the proportion of the event of interest is >10%, the
odds ratio (OR) overestimates the prevalence ratio (PR).
Alternative methods have been described in the literature for
the analysis of binary outcomes in longitudinal studies, includ-
ing using the PR instead of the OR. The Cox model with robust
variance is valid for estimating the PR [26].
To explore the association between the time variable and
the events of interest in the complete cohort, PRs and 95% confi-
dence intervals (CIs) were calculated using a Cox regression
model with robust variance. As recommended, in the Cox
model, a constant risk period equal to one was assigned to every
patient in the cohort [26].
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To evaluate the association between the time variable and
CAPD utilization, analyses were restricted to the cohort of
patients on assisted PD and subsequently to the nurse-assisted
PD and family-assisted PD subgroups.
Cumulative incidence curves were drawn for each possible
PD outcome (death, transfer to HD and renal transplantation)
and for peritonitis events. Technique survival and peritonitis
rates according to the type of assistance were compared using
the Logrank test. Conditional probabilities for the event of inter-
est were estimated at specific time points.
A bivariable analysis was performed to estimate the associa-
tion between each variable and the event of interest. The time
variable was included a priori in the multivariate analysis; other-
wise, variables were included in the model based on the results
of the change in the estimate procedure with a cut-off value of
10%. Interactions between time and the other covariates were
tested in the multivariate models.
Missing data were <5%, enabling us to use a complete case
analysis. Analyses were performed with R 3.4.3 (R Foundation




Of the 11 987 incident patients on PD included in the study, 6149
(51%) patients were on assisted PD: 5052 (82%) were on nurse-
assisted PD and 1097 (18%) were on family-assisted PD. The
number of patients starting PD per year is displayed in Figure 1.
The median [interquartile range (IQR)] time on PD was
19.3 months (8.4–34.5 months). Compared with self-care PD
patients, those on assisted PD were older, more frequently dia-
betic and had more comorbidities. Patient characteristics
according to the type of assistance are described in Table 1.
Incident patients’ age and CCI by year of PD start are described
in Table 2.
Association between calendar time and the rate of
assisted PD utilization
In the multivariable analysis, time was associated with the as-
sisted PD rate, whether included in the regression model as a
regression spline (Figure 2) or as a categorical variable (Table 3).
The year 2013 was the time point with the lowest rate of as-
sisted and nurse-assisted PD utilization and was chosen as the
reference class in the corresponding modelling. There was a lin-
ear relationship between time and family-assisted PD utiliza-
tion; thus, the PD start year was defined as a linear variable in
this model.
Compared with 2013, starting PD in 2006, 2007, 2008, 2009,
2010, 2012 or 2015 was strongly associated with the utilization
of assisted PD. Nurse-assisted PD utilization increased signifi-
cantly after 2012, whereas family-assisted PD utilization de-
creased linearly over time (PR ¼ 0.94, 95% CI 0.92–0.97; Table 3).
Age, gender, diabetes, modified CCI, a suboptimal start, un-
derlying nephropathy, renal replacement therapy before PD ini-
tiation and centre experience were associated with assisted PD
(Table 3). There were no significant interactions between PD
start year and the other covariates.
Association between calendar time and the rate of CAPD
utilization in the assisted PD, nurse-assisted PD and
family-assisted PD subgroups
Based on the shape of the regression spline, the PD start year
for this part of the analysis was transformed into a categorical
variable composed of three classes: 2006–10, 2010–12 (reference
class) and 2012–15. In the unadjusted and adjusted analyses,
the PD start year was associated with an increased rate of CAPD
utilization, whether included in the Cox regression model as a
regression spline (data not shown) or as a categorical explana-
tory variable (Table 4).
Starting PD in 2012, 2013, 2014 or 2015 was strongly associ-
ated with an increased rate of CAPD utilization (PR ¼ 1.16, 95%
CI 1.08–1.23). The PR change over time followed a similar pat-
tern in nurse-assisted PD patients (PR ¼ 1.13, 95% CI 1.05–1.21)
and family-assisted PD patients (PR ¼ 1.24, 95% CI 1.03–1.49;
Table 4).
Age, gender, modified CCI, a suboptimal start, therapy before
PD initiation and centre experience were associated with CAPD
initiation (Table 4). There were no significant interactions be-
tween PD start year and the other covariates.
Technique survival and peritonitis rates according to the
type of assistance
The median (IQR) PD duration for the complete cohort was
16.9 months (7.38–30.9). There were 10 942 (91%) PD failures dur-
ing the study period, including 4252 (35%) deaths and 3648 (30%)
transfers to HD. Furthermore, 2262 (19%) patients had a renal
transplantation. According to the type of assistance, the median
(IQR) PD duration was 16.6 months (6.1–31.5) and 15.5 months
(7.1–31.3) for patients on nurse- and family-assistance, respec-
tively. Technique survival rates did not differ according to the
type of assistance (P¼ 0.57). Conditional probabilities using the
cumulative incidence method for the events are provided in
Table 5.
In the complete cohort, there were 4421 (37%) episodes of
peritonitis, with a median (IQR) time to peritonitis of 8.9 months
(3.1–19.6). There were 1826 (36%) episodes of peritonitis in the
nurse-assistance group and 406 (37%) in the family-assistance
group. Median (IQR) time to peritonitis were of 8.8 months (2.8–
19.8) and 8.5 months (2.2–20.3), respectively. Patients on nurse
assistance tended to have less peritonitis compared with
patients on family assistance even though the results were not
significant (P¼ 0.08). The cumulative incidence of peritonitis atFIGURE 1: Number of patients starting PD per year over the study period.
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2 years was of 50.5, 49.4 and 52.1% for the complete cohort,
nurse-assistance and family-assistance groups, respectively.
DISCUSSION
Assisted PD programmes are available in different countries
around the world, with differences from one country to another
[12]. To our knowledge, the trend in the utilization of assisted
PD among incident PD patients over time has not yet been docu-
mented at a national level. We hereby provide a description of
the utilization of assisted PD over a decade in a country where
assisted PD has been available for >30 years and is fully covered
by healthcare insurance. The high exhaustivity of the RDPLF
makes it a reliable database [22, 23].
With the CKD population growing older and frailer, it would
be anticipated that the use of assisted PD should increase over
the years. However, our results show a different pattern; there
was a decline in the rate of assisted PD until 2013, while the to-
tal number of dialysed patients continued to increase [19]. The
decline in the assisted PD rate was mainly attributed to a linear
decline in family-assisted PD utilization.
In contrast, after 2013, there was an increased utilization of
nurse-assisted PD over time (Figure 2). Surprisingly, patients’
age and comorbidities remained stable during the study period
(Table 2), leading to the hypothesis that the potential rate of
patients who needed assistance did not decrease during the
decade.
The linear decline observed in family-assisted PD utilization
could be explained by several factors. First, there was a modifi-
cation in the state of health of caregivers. In a French survey
published in 2008, 48% of the caregivers were suffering from
chronic disease, and 29% declared that they were suffering from
anxiety and stress [27]. Life expectancy has been rising in
France over the past decade; however, while life expectancy
without disability remains stable (64.5 years old for women and
63.4 years old for men) [28], the number of people suffering from









2006 71.5 (55–80.4) 4 (2–5) 96 (8)
2007 69.4 (55.9–79.7) 3 (2–5) 108 (9)
2008 68.8 (53.6–78.9) 3 (2–5) 109 (10)
2009 70.3 (54.8–80.9) 4 (2–5) 110 (9)
2010 69.8 (54.6–80.2) 4 (2–5) 108 (10)
2011 67.2 (53–80.2) 3 (2–5) 105 (9)
2012 70 (54.6–80) 3 (2–5) 110 (9)
2013 67.2 (53.9–80.1) 3 (2–5) 129 (10)
2014 68.4 (55.6–80.2) 3 (2–5) 136 (10)
2015 69.9 (56.2–80.7) 4 (2–5) 152 (11)










Age at PD initiation, median (IQR)a 69.2 (54.7–80.1) 79.6 (72.3–84.6) 74.3 (65–81.7) 56.5 (43.9–67.1)
Gender (male), n (%) 7101 (59) 2686 (53) 674 (62) 3741 (64)
Diabetes, n (%) 4026 (34) 2204 (44) 529 (48) 1293 (22)
Modified CCI, median (IQR) 3 (2–5) 4 (3–6) 5 (3–6) 3 (2–4)
Underlying nephropathy, n (%)
Diabetic 2372 (20) 1247 (25) 312 (29) 813 (14)
Interstitial nephritis 784 (7) 276 (6) 64 (6) 444 (8)
Glomerulonephritis 1827 (15) 283 (6) 91 (8) 1453 (25)
Polycystic kidney disease 800 (7) 109 (2) 29 (3) 662 (11)
Unknown 1359 (11) 625 (12) 115 (10) 619 (11)
Uropathy 525 (4) 112 (2) 32 (3) 381 (6)
Vascular 3828 (32) 2256 (45) 412 (38) 1160 (20)
Systemic disease 333 (3) 83 (1) 22 (2) 228 (4)
Other 105 (1) 41 (1) 12 (1) 52 (1)
Missing 54 20 8 26
Suboptimal starters, n (%) 1131 (9) 558 (11) 105 (10) 468 (8)
Treatment before PD, n (%)
No therapy 9486 (79) 4188 (83) 860 (78) 4438 (76)
HD 2072 (17) 815 (16) 222 (20) 1035 (18)
Renal transplantation 406 (4) 40 (1) 15 (2) 351 (6)
Missing 23 9 0 14
First PD modality (CAPD), n (%) 8971 (75) 4357 (86) 801 (73) 3813 (65)
Type of centre, n (%)
Community hospital 5763 (48) 2562 (51) 528 (48) 2673 (46)
Academic hospital 2326 (20) 893 (18) 204 (19) 1229 (21)
Non-profit 2863 (24) 1107 (22) 268 (24) 1488 (25)
Private hospital 1035 (8) 490 (9) 97 (9) 448 (8)
Centre experience, n (%)
(new patients per year)
10 4746 (40) 1964 (39) 437 (40) 2345 (40)
>10 7241 (60) 3088 (61) 660 (60) 3493 (60)
aIn years.
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chronic disease has been constantly rising [29, 30]. The number
of caregivers in France is estimated to be 11 million, of which al-
most 35% are aged >60 years old, and 74% feel that being a care-
giver has an impact on their own health [31, 32].
Secondly, social deprivation in the elderly (>75 years old)
has been increasing steadily; in 2014, 27% of elderly individuals
were considered to live with social deprivation compared with
16% in 2010. The population with social deprivation is now
composed of more than a quarter of the people aged >75 years.
This increase has been associated with a combination of several
factors: an increase in the proportion of elderly people with
disabilities, a relative decline in associative practices and a
loosening in family relationships [33].
Finally, the proportion of patients on PD with a CCI >7 did
not decrease over time (Table 2), reflecting frailty and depen-
dency, which could influence the caregiver’s burden. The in-
crease in caregiver burden, often associated with a reduction in
psychological health, has been previously reported [34, 35]. It
has recently been shown that a high proportion of patients will
observe a decline in functional status in the first 6 months after
initiating dialysis. In this study, the percentage of caregivers
reporting a high burden of care increased from 23 to 38% after
dialysis initiation [36]. In a study from our team, compared with
autonomous PD patients, patients with nurse assistance had a
lower risk of transfer to HD, while those with family assistance
had a similar risk of transfer to HD. This finding could be partly
explained by the usefulness of nurse assistance to reduce the
burden of PD for both patients and their families [11, 37, 38]. As
the caregiver burden increased over time, family assistance de-
clined. Interventions will be needed in the future to remove this
burden and facilitate the task of caregivers.
On the other hand, the recent uptake in nurse-assisted PD
could be explained by economic incentives and/or better cover-
age of home dialysis.
Economic incentives to increase home dialysis by altering
remuneration for these therapies are being introduced in some
countries. A recent workshop concluded that economic incen-
tives were effective at increasing the use of home dialysis [17].
However, the time until an impact on incident home dialysis
numbers can be observed remains unclear.
In France, nursing homes receive a financial budget from the
healthcare insurance that covers collective medical costs
(humans resources and medical devices). The nursing time ded-
icated to each patient is based on a standard medical care eval-
uation. However, patients on PD might need assistance up to
four times a day, 7 days a week, increasing the need for human
resources. Nurse-assisted PD is fully covered by the healthcare
insurance in France; however, prior to 2011, no fee was paid if
the patient resided in a nursing home [39]. According to
Dratwa et al., the evaluated additional costs generated by
nurse-assistance were 23 400 e/patient/year for CAPD (four
exchanges per day) and 18 200 e/patient/year for APD [39]. Most
nursing homes were not willing to pay for these additional
charges. As a consequence, most end-stage renal disease
patients on PD did not have access to nursing homes or had to
change modality to HD to be accepted. Thanks to an economic
FIGURE 2: PR of assisted PD initiation over time. Change in the PR of assisted PD initiation over time. Solid lines represent the rates of receiving assisted PD at any point
during follow-up, by the year PD was initiated, when compared with 2006 (expressed as a PR). The analysis was adjusted for age, gender, ethnicity and underlying ne-
phropathy using a Cox regression model with robust variance (95% CI shown by dashed lines). The assisted PD PR over the study period was not linear. The PR for assis-
ted PD was defined as PD performed at the patient’s home with the help of a community nurse or a family member (a), for nurse-assisted PD only (b) and family-
assisted PD only (c).
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incentive implemented in November 2011, the fees generated
by nurse assistance are now fully covered, even if the patients
reside in a nursing home [21]. That means that private nurses
are paid, since 2011, to perform PD in the nursing home. We be-
lieve that this incentive translated into an increase in nurse-
assisted PD from 2013.
The funding models for dialysis can also impact the use of
home dialysis. In the USA, the prospective payment system, a
bundle payment, for the US Medicare End-Stage Renal Disease
Programme was launched in January 2011. It reduced financial
disincentives for facility use of home therapies. PD payment
was set to be equivalent to in-centre HD treatment. The number
of patients on PD increased by 15% between 2011 and 2013 [17],
40]. There was an increasing tendency of patients on PD to be
treated in facilities with less PD experience, without any
changes in mortality rates. This finding suggests a link between
the funding model and the modality distribution [17, 40, 41].
As shown by the adjusted Cox model, the relative use of
CAPD increased over the study period, notably between 2012
and 2015 (PR ¼ 1.16, 95% CI 1.08–1.23). This increase was noted
in both nurse- (PR ¼ 1.13, 95% CI 1.05–1.21) and family-assisted
PD (PR ¼ 1.24, 95% CI 1.03–1.49). In a recent study from our team,
technique survival and peritonitis-free survival were similar be-
tween CAPD and APD in assisted PD patients [42]. In addition, a
study of incident self-PD patients demonstrated a similar qual-
ity of life in both modalities, underlining the importance of the
patient’s choice [43]. Both modalities should be offered to assis-
ted PD patients; however, in view of the CAPD rate, one may
wonder if APD is considered by the PD team to be equally suit-
able as CAPD for assisted patients with physical disabilities or
cognitive dysfunctions. Moreover, nursing homes are often re-
luctant to deal with cyclers during the night because of the
small number of caregivers available at night in those facilities.
Older age, diabetes, a higher CCI and underlying nephropa-
thy were also associated with an increased probability of assis-
ted PD initiation, likely a reflection of increased comorbidity,
frailty and dependency. Similar findings have been described
previously [11, 25]. It has been demonstrated that functional
Table 3. Association between PD start year and the PR of assisted PD initiation, adjusting for patient characteristics, for each type of assistance
Explanatory variable
All assistance Nurse-assistance Family-assistance
PR (95% CI) PR (95% CI) PR (95% CI)
PD start year (reference¼ 2013) PD start yeara
2006 1.17 (1.07–1.29) 1.08 (0.96–1.22) 0.94 (0.92–0.97) a
2007 1.27 (1.15–1.39) 1.19 (1.05–1.34)
2008 1.24 (1.12–1.37) 1.13 (0.99–1.27)
2009 1.21 (1.10–1.32) 1.18 (1.05–1.33)
2010 1.14 (1.04–1.26) 1.14 (1.02–1.28)
2011 1.09 (0.99–1.21) 1.08 (0.96–1.21)
2012 1.16 (1.06–1.28) 1.15 (1.03–1.27)
2013 Reference Reference
2014 1.08 (0.99–1.19) 1.14 (1.02–1.29)
2015 1.12 (1.03–1.23) 1.24 (1.11–1.34)
Age, for a 10-year increase 1.79 (1.75–1.83) 1.83 (1.79–1.88) 1.19 (1.14–1.25)
Gender, male 0.71 (0.68–0.74) 0.70 (0.66–0.73) 1.06 (0.94–1.20)
Diabetes 1.13 (1.07–1.20) 1.10 (1.03–1.18) 1.21 (1.02–1.44)
Modified CCI (per unit) 1.09 (1.08–1.11) 1.06 (1.05–1.08) 1.14 (1.10–1.18)
Suboptimal starters 1.11 (1.04–1.19) 1.17 (1.07–1.26) 0.90 (0.73–1.10)
Underlying nephropathy
Polycystic kidney disease Reference Reference Reference
Diabetes 2.30 (1.93–2.74) 2.16 (1.77–2.63) 1.93 (1.26–2.96)
Interstitial nephritis 2.16 (1.79–2.61) 2.04 (1.65–2.51) 2.02 (1.28–3.18)
Glomerulonephritis 1.36 (1.13–1.63) 1.26 (1.02–1.55) 1.42 (0.92–2.18)
Unknown 2.18 (1.83–2.59) 2.09 (1.72–2.54) 1.73 (1.13–2.66)
Uropathy 1.84 (1.48–2.29) 1.72 (1.34–2.21) 1.79 (1.06–2.99)
Vascular 2.35 (1.99–2.78) 2.22 (1.84–2.68) 1.91 (1.27–2.87)
Systemic disease 1.87 (1.47–2.38) 1.77 (1.35–2.33) 1.72 (0.97–3.04)
Other 2.23 (1.68–2.95) 2.06 (1.50–2.82) 2.43 (1.18–5.01)
Therapy before PD initiation
No therapy Reference Reference Reference
HD 1.14 (1.08–1.20) 1.04 (0.97–1.12) 1.32 (1.13–1.54)
Transplantation 0.54 (0.41–0.71) 0.54 (0.39–0.74) 0.67 (0.39–1.15)
Type of centre
Academic hospital Reference Reference Reference
Community hospital 1 (0.95–1.07) 1.03 (0.96–1.11) 0.94 (0.79–1.11)
Non-profit 1 (0.93–1.07) 0.98 (0.90–1.07) 1.08 (0.90–1.30)
Private hospital 0.94 (0.87–1.02) 0.94 (0.84–1.04) 0.99 (0.77–1.28)
Centre experience (new patients per year)
10 Reference Reference Reference
>10 1.14 (1.09–1.20) 1.17 (1.10–1.23) 0.99 (0.87–1.13)
aAccording to the spline regression, PD start year was modelled as a linear variable (per year).
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impairment is highly prevalent in older patients on assisted PD
and is associated with comorbidities [44].
Technique survival and peritonitis rates in our popu-
lation were similar to previous studies [11, 45]. Both types
of assistance have been associated with a lower risk for tech-
nique failure or transplantation, but a higher risk for death as
the patients were older and frailer [11]. In older patients, nurse
assistance has been associated with a lower risk for peritonitis
[45]. Our findings are in line with previous studies, demon-
strating the sustainability of assisted PD.
The use of PD remains low in France, with <10% of patients
utilizing this modality [19]. Over time, patients starting dialysis
seem to be older and more likely to be diabetic and have cardio-
vascular or respiratory comorbidities [19]. The use of assisted
PD could reflect a nephrologist preference for this modality for
older and frailer patients.
Our study has limitations; by nature, the observational de-
sign cannot lead to conclusions regarding causality. We have
shown results on the use of assisted PD compared with all PD
utilization; however, this study was not designed to show an ef-
fect on overall PD utilization as this would require data on all re-
nal replacement therapy patients. Although the use of
assistance can change over time, only the assistance at dialysis
start was used for the analysis. Because of the particularity of
the coverage in France, assisted PD utilization might differ from
other countries, which could limit the generalizability of our
results. However, we believe that the results of our study could
help centres anticipate what could possibly happen in the fu-
ture when implementing an assisted PD programme.
Our study also shows that, due to a decline in family assis-
tance, assisted PD currently relies mainly on nurse assistance. It
has been demonstrated that widespread adoption of assisted
Table 4. Association between PD start year and the PR of CAPD initiation, adjusting for patient characteristics, for each type of assistance
Explanatory variable
All assistance Nurse-assistance Family-assistance
PR (95% CI) PR (95% CI) PR (95% CI)
PD start year (category)
2010–12 Reference Reference Reference
2006–10 1.04 (0.97–1.11) 1.02 (0.94–1.09) 1.17 (0.98–1.41)
2012–15 1.16 (1.08–1.23) 1.13 (1.05–1.21) 1.24 (1.03–1.49)
Age, for a 10-year increase 1.20 (1.17–1.23) 1.17 (1.14–1.21) 1.21 (1.15–1.29)
Gender, male 0.95 (0.91–1.01) 0.96 (0.91–1.01) 0.98 (0.86–1.12)
Diabetes 0.99 (0.94–1.06) 1.02 (0.95–1.08) 0.90 (0.76–1.07)
Modified CCI (per unit) 1.02 (1.01–1.03) 1.02 (1.01–1.03) 1.02 (0.99–1.06)
Suboptimal starters 0.90 (0.83–0.97) 0.92 (0.84–0.99) 0.77 (0.59–0.99)
Underlying nephropathy
Polycystic kidney disease Reference Reference Reference
Diabetes 1.03 (0.86–1.24) 1.07 (0.87–1.32) 0.93 (0.60–1.46)
Interstitial nephritis 1.13 (0.93–1.38) 1.15 (0.93–1.44) 1.04 (0.64–1.70)
Glomerulonephritis 1.04 (0.85–1.27) 1.10 (0.88–1.37) 0.88 (0.55–1.42)
Unknown 1.07 (0.89–1.28) 1.14 (0.93–1.40) 0.78 (0.49–1.25)
Uropathy 1.21 (0.96–1.52) 1.27 (0.99–1.63) 1.11 (0.63–1.96)
Vascular 1.18 (0.99–1.40) 1.21 (1–1.46) 1.10 (0.72–1.68)
Systemic disease 0.94 (0.72–1.24) 1 (0.74–1.36) 0.72 (0.37–1.38)
Other 0.96 (0.68–1.35) 1 (0.69–1.45) 0.91 (0.39–2.11)
Therapy before PD initiation
No therapy Reference Reference Reference
HD 0.86 (0.80–0.93) 0.86 (0.80–0.93) 0.91 (0.77–1.09)
Transplantation 0.71 (0.50–1.01) 0.63 (0.42–0.95) 1.01 (0.54–1.88)
Type of centre
Academic hospital Reference Reference Reference
Community hospital 0.84 (0.79–0.90) 0.79 (0.74–0.85) 1.01 (0.54–1.88)
Non-profit 0.99 (0.93–1.06) 0.92 (0.86–0.99) 1.37 (1.12–1.66)
Private hospital 0.94 (0.86–1.03) 0.87 (0.80–0.96) 1.31 (1.04–1.67)
Centre experience (new patients per year)
10 Reference Reference Reference
>10 0.93 (0.88–0.97) 0.91 (0.87–0.96) 0.94 (0.82–1.08)
Table 5. Cumulative incidence of PD outcomes at specific times












Death 8.7 17.2 26.4 37.7
Transfer to HD 9 16.6 25.5 34.5
Renal transplantation 3.3 9.8 16.6 24.5
Nurse-assisted PD patients
Death 15.9 30.2 45.9 64.2
Transfer to HD 8.7 13.9 20.3 26.4
Renal transplantation 0.5 1 1.8 2.6
Family-assisted PD patients
Death 13.6 28.8 41.4 60.9
Transfer to HD 8.7 17.2 27.7 34.1
Renal transplantation 0.8 3.3 6.1 7.6
Results are expressed as percentages.
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PD services would significantly increase PD initiation [46].
Although there are added costs to nurse-assisted PD, a
Netherlands study demonstrated that it is a cost-effective op-
tion [47] in elderly patients. To further develop PD utilization in
developed countries, nurse assistance should be promoted. We
believe that assisted PD programmes, notably nurse assistance,
should be implemented in every PD centre to increase PD utili-
zation [48]. Alternatively, economic incentives to the patient’s
family could be considered, to convince relatives to participate
in PD care. Such incentives do not exist in France currently.
In conclusion, this study shows that in France, the assisted
PD rate decreased until 2013, mainly because of the decline of
family assistance. The uptake in nurse-assisted PD observed
from 2013 probably reflects the effect of an economic incentive
adopted in late 2011 to increase PD utilization for end-stage re-
nal disease patients in nursing homes.
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31. Haute Autorité de Santé: Le soutien des aidants non profession-
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